The PGS test and the FDA’s subsequent order of 23andMe to cease marketing the test to consumers has stirred controversy, and brought focus to an issue labs may have to face sooner rather than later: What role should labs play in whole-genome sequencing performed for health screening?
More news on FDA 23 and Me ( Click on this link for Dec 2014 news below):
END YOUR ILLNESS 
Reblogged this on Depression is Not Your Fault.
LikeLike